BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, December 29, 2025
Home » Topics » Briefs » In the clinic

In the clinic
In the clinic RSS Feed RSS

In the clinic for July 6, 2020

July 6, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: 4D, Adverum, Avrobio, Anavex, Bellus, Celixir, CSL, Deciphera, Gensight, Gilead, Idorsia, Immunomedics, Inventiva, Merck, Myovant, Obseva, Oryzon, Sunovion, Regeneron, Sanofi.
Read More

In the clinic for July 2, 2020

July 2, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Berlin Heart, Osteolabs, Pulse Biosciences.
Read More

In the clinic for July 2, 2020

July 2, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: 4D, Abivax, Apellis, Biocardia, Menarini, Moleculin, Pfizer, Vaccibody.
Read More

In the clinic for July 1, 2020

July 1, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abiomed, Biomodex, Elucid Bio.
Read More

In the clinic for July 1, 2020

July 1, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Akero, Anavex, Biondvax, Biontech, Context, Corcept, Daiichi, Durect, Eyenovia, Ipsen, Matinas, Oncolys, Pfizer, Polypid, Revance, Timber, Vasopharm.
Read More

Clinical data for June 23-29, 2020

June 30, 2020
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Algernon, Cytodyn, Fibrogen, Immutep, Montreal Heart Institute, Noxopharm, Revimmune.
Read More

In the clinic for June 30, 2020

June 30, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Cvrx, Datos Health, Genetron, Reneuron.
Read More

In the clinic for June 30, 2020

June 30, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alnylam, Altimmune, Amniox, Aobiome, Beyondspring, Blueprint, Can-Fite, Depuy, Exelixis, Galectin, Genmab, Humanigen, Impel, Inovio, Iveric, Marinus, Meissa, Nordic Nanovector, Novartis, Noxxon, Oncternal, Orexo, Orthocell, Reneuron, Revance, Rheacell, Roche, Rubius, Seattle Genetics, Zynerba.
Read More

In the clinic for June 29, 2020

June 30, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: 9 Meters, Achieve, Aileron, Biocardia, Cytodyn, Immutep, Immunovant, Intra-Cellular, Iterum, Kiniksa, KPB, Medicure, Revimmune, TFF, Tonix.
Read More

In the clinic for June 26, 2020

June 26, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Biocartis, Intact Vascular, Neovasc, Royal Philips.
Read More
Previous 1 2 … 269 270 271 272 273 274 275 276 277 … 311 312 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 29, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 29, 2025.
  • Illustration of magnifying glass looking at cancer in the brain

    Researchers discover how glioblastoma tumors dodge chemotherapy

    BioWorld MedTech
    Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
  • Businessman, businesswoman handshake

    Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact

    BioWorld
    Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
  • Asia focused map inside light bulb

    Big pharma taps fast Asia innovation in search of next Keytruda

    BioWorld
    Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing